Limas Kupcinskas

Plain English
This study looked at liver problems that occurred after COVID-19 vaccinations, trying to figure out whether these issues were caused by a vaccine-triggered autoimmune condition or a temporary reaction to the vaccine. The research followed 62 patients over nearly two years, finding that 93% of them received steroids to treat their liver issues, and after 6 months, 71% of patients saw their liver enzyme levels return to normal. While most patients showed improvement, a smaller group needed ongoing treatment, indicating that some might have a more serious condition related to the vaccine. Who this helps: This research benefits patients who have experienced liver injury after COVID-19 vaccination, as well as their doctors in understanding how to treat them.

Plain English
This study looked at a rare autoimmune disease called IgG4-related disease (IgG4-RD), which can impact various organs. The case reported involved a patient suffering from issues like pancreatitis, severe malnutrition, and inflammation of the salivary glands and bile ducts. After treatment with two medications, prednisolone and mycophenolate mofetil, the patient's health improved significantly. Who this helps: This helps patients with IgG4-related disease and their doctors.

Plain English
This study looked at specific proteins called DPP-4 and NPY in the intestines of patients who are obese, some of whom also have type 2 diabetes. Researchers found that the levels of these proteins vary between patients with and without diabetes, and certain gastrointestinal symptoms like abdominal pain and constipation were linked to these proteins in those without diabetes. Understanding these differences is important because it may lead to better treatments for gastrointestinal issues related to obesity and diabetes. Who this helps: This helps patients struggling with obesity and gastrointestinal symptoms, especially those without diabetes.

Plain English
This study looked at the presence of a specific infection in adults in Kaunas, Lithuania, and how it is related to age, education, and environmental factors. Researchers tested over 1,000 adults and found that about 63% had the infection, with the rate rising to 80% among older men. This finding is important because it indicates a high prevalence of the infection in the population, which could lead to serious health issues like stomach cancer. Who this helps: Patients at risk for stomach cancer and healthcare providers managing their care.

Plain English
This study looked at how two hormones, GLP-1 and GIP, affect muscle contractions in the intestines of obese patients with and without type 2 diabetes. Researchers found that in patients with type 2 diabetes, the hormone GIP was lower and muscle contractions were weakened, while GLP-1 was higher but mainly reduced contractions in certain muscle layers. Understanding these interactions is important because they can help address issues with gut movement in people with type 2 diabetes, which can lead to digestive problems. Who this helps: This helps patients with type 2 diabetes who experience gut motility issues.

Plain English
This study looked at how effective a new treatment option is for patients with severe ulcerative colitis who did not respond to previous treatments. Out of 78 patients, the new treatment helped prevent surgery (colectomy) in about 63% of them, with 32 patients achieving clinical remission after 12 weeks and 18 after 52 weeks. The findings suggest that using a third-line treatment can be a viable strategy to manage this condition and avoid surgery. Who this helps: Patients with severe ulcerative colitis who haven't benefited from earlier treatments.

Plain English
In Lithuania, health authorities started a screening program for hepatitis C in May 2022 to work towards eliminating the virus by 2030. In the first year, 790,070 people were tested, revealing that 11,943 (1.5%) tested positive, with a higher prevalence in men (1.9%) compared to women (1.2%). To meet World Health Organization targets, Lithuania needs to treat an additional 2,180 patients every year until 2030 to prevent future infections and save lives. Who this helps: This benefits patients at risk for hepatitis C, including those born between 1945 and 1994 and those who inject drugs.

Plain English
This study looks at how the hepatitis C virus (HCV) was discovered and the development of new medications that can cure the infection, along with strategies to completely eliminate HCV worldwide by 2030. It highlights that to meet the World Health Organization's goals—a 90% decrease in new cases and treating 80% of infected individuals—findings show we need better screening, accessible medication, and ongoing care. The research emphasizes that comprehensive programs are essential for successfully tackling HCV and requires strong support from governments and funding. Who this helps: This helps patients living with hepatitis C, doctors treating them, and public health officials planning elimination strategies.

Plain English
This study looked at 59 people who developed liver problems after receiving a SARS-CoV-2 vaccine. Most of these individuals (76%) showed a particular type of liver inflammation, and many had positive tests for autoimmune antibodies, suggesting their immune systems were mistakenly attacking their own liver cells. After treatment with steroids, most patients improved, with 41% returning to normal liver function within three months, but some may need long-term monitoring to ensure their liver stays healthy. Who this helps: This information is important for doctors treating patients who experience liver issues after vaccination.

Plain English
This research studied the causes and outcomes of acute liver failure (ALF) in adults and children across Europe. Researchers collected data from 455 cases in 2020, finding that intoxication was the leading cause in both age groups. The study highlights that there are many effective diagnostic tools and treatment methods available, showing the expertise of the centers involved. Who this helps: This benefits patients and healthcare providers dealing with liver failure.

Plain English
This study looked at the different types of the hepatitis C virus (HCV) and the severity of liver damage in patients from Estonia, Latvia, Lithuania, and Ukraine. It found that 66.4% of patients had the most common HCV type (genotype 1), and 20.9% had severe liver damage known as cirrhosis. This information is important because it can help healthcare systems in these countries prioritize patients for effective treatments and manage resources better. Who this helps: This benefits patients with hepatitis C and healthcare providers in the Baltic states and Ukraine.

Plain English
This study looked at how doctors in Europe treat Helicobacter pylori infections, which can cause stomach problems. They analyzed data from over 26,000 patients and found several common mistakes: for instance, doctors used ineffective standard treatment 46% of the time, prescribed short treatment durations for 69% of patients, and did not adequately check if the treatment worked in 6% of cases. These findings matter because they highlight areas where treatment can be improved, ultimately leading to better health outcomes for patients. Who this helps: Patients with Helicobacter pylori infections.

Plain English
This study looked at tissue samples from patients with atrophic gastritis (AG) and gastric cancer (GC) to find specific microRNAs (tiny molecules that help control gene activity) that could help diagnose these conditions early. The researchers analyzed samples from 125 people and found two microRNAs, hsa-miR-129-1-3p and hsa-miR-196a-5p, that were increasingly abnormal as the disease progressed, showing potential to distinguish between healthy individuals and those with AG or GC with accuracy rates ranging from 66.3% to 93.1%. These findings are important because they could lead to earlier and more reliable diagnosis of gastric cancer, which typically has a poor prognosis when detected late. Who this helps: This helps patients at risk for gastric cancer and doctors looking for better diagnostic tools.

Plain English
This study looked at the possibility of eliminating hepatitis C virus (HCV) infections in Central European countries, particularly in prisons where HCV is most common. Researchers found that nearly 400,000 people in these countries are still infected, and treatments have dropped significantly—by half—over the last two years, mainly due to the COVID-19 pandemic. None of the countries have established national screening programs to identify infections, making it unlikely they can meet the World Health Organization's goal of eliminating HCV as a public health threat by 2030. Who this helps: This benefits patients, especially those in prisons who are at high risk of HCV infections.

Plain English
This study looked at hepatitis C virus (HCV) infections and related deaths in Lithuania before a new national screening program was introduced. Researchers found that among patients with liver cirrhosis, 40.5% had HCV, while 49.7% of cancer patients and 36.9% of transplant patients also tested positive for the virus. In a pilot screening at a health center, 1.7% of those tested had HCV, with rates higher in men and linked to factors like prior blood transfusions and tattoos. Who this helps: This benefits patients at risk of hepatitis C, especially those with liver diseases and healthcare providers who can identify and manage these infections.

Plain English
This study looked at whether adding budesonide, a steroid medication, could help patients with primary biliary cholangitis (PBC) who were still experiencing liver issues despite taking another medication called ursodeoxycholic acid (UDCA). Out of 62 patients, those who took budesonide showed better improvements in liver blood tests, with 35% achieving normal results compared to just 9% in the placebo group. However, there were no significant improvements in liver tissue quality, meaning budesonide didn’t help heal the liver as hoped. Who this helps: This research benefits patients with PBC and their doctors by providing insight into treatment options when UDCA alone isn’t enough.

Plain English
This research studied how European doctors treat infections caused by a bacteria called Helicobacter pylori in over 30,000 patients across 27 countries. The findings showed that common treatments, like a three-drug combination, were only effective about 81.5% of the time, while better results (over 90% effectiveness) were achieved with certain four-drug regimens lasting at least 10 days. This research highlights that treatment approaches vary widely and many doctors are not following the best updated guidelines, which can lead to less effective care. Who this helps: This helps patients with Helicobacter pylori infections by guiding doctors to use more effective treatment strategies.

Plain English
This study looked at changes in the cells of the stomach that can lead to gastric cancer, specifically focusing on a condition called intestinal metaplasia. Researchers found various genetic changes and shifts in the bacteria present in the stomach that are linked to this condition, which could help in early detection and treatment of gastric cancer. For instance, some molecular changes were strongly associated with intestinal metaplasia, indicating their potential use in screening at-risk patients. Who this helps: This information benefits patients at risk of gastric cancer and doctors aiming for personalized treatment approaches.

Plain English
This study looked at the liver infection called HCV (hepatitis C) in Central Europe and found that between 0.2% and 1.7% of people in certain countries are affected. While patients can access effective treatments, the lack of national screening programs and political support, along with the impact of Covid-19, means that reaching the goal of eliminating HCV by 2030 is unlikely in this region. Addressing these barriers is crucial for improving health outcomes. Who this helps: This helps patients with hepatitis C and healthcare providers working to treat and eliminate the infection.

Plain English
This study looked at how certain genetic factors might be linked to diverticulitis and diverticulosis, two conditions related to the colon. Researchers analyzed DNA from 1,332 patients who had undergone colonoscopies and found that a specific gene variant (FAM155A) was associated with a reduced risk of developing diverticulitis, but not diverticulosis, indicating that different genetic factors may play roles in these conditions. This finding is important because it can help identify which patients are more at risk for diverticulitis, allowing for better prevention and treatment strategies. Who this helps: This helps patients at risk for diverticulitis and their doctors in managing their health.

Plain English
This study looked at how close Central European countries are to eliminating hepatitis C by 2030. Researchers found that the number of people infected with hepatitis C varies from 0.2% in some countries to 1.7% in others. While most countries can afford treatment and have access to necessary medications, they lack the political support and national screening programs needed to reach elimination goals, making it unlikely that this will be achieved by the 2030 deadline. Who this helps: Patients with hepatitis C and healthcare providers managing their treatment.

Plain English
This study examined how effective different treatments are for patients allergic to penicillin who have an infection caused by Helicobacter pylori. The researchers found that a quadruple treatment (consisting of a proton pump inhibitor, bismuth, tetracycline, and metronidazole) successfully eradicated the infection in 91% of cases, while a lesser-used triple treatment (with clarithromycin instead of bismuth) was only effective in 69% of cases. This is important because it shows that the quadruple regimen is significantly more successful and should be the preferred option for these patients. Who this helps: Patients allergic to penicillin who need treatment for Helicobacter pylori infections.

Plain English
This study explored the connection between migraines, celiac disease, and non-celiac gluten sensitivity (NCGS) by looking at the enzyme diamine oxidase (DAO), which helps break down histamine. They found that among 44 patients with severe migraines, 26 had low DAO activity, and 10 were diagnosed with NCGS, with 9 of those also having low DAO activity. This is important because it suggests that people with migraines may benefit from checking their DAO levels and considering dietary changes, especially those related to gluten. Who this helps: Patients who suffer from migraines and may have celiac disease or gluten sensitivity.

Plain English
This study looked at the bacteria found in stomach biopsies from patients with gastric cancer and digestive issues to see if the bacteria present were temporary contaminants or long-term residents. The researchers found that after washing the samples, the number of temporary bacteria decreased, indicating they were likely not a permanent part of the stomach's microbiome. They also noted significant differences in bacterial diversity based on whether patients were positive or negative for a specific factor, suggesting it plays a key role in shaping the stomach's bacteria. Who this helps: This benefits patients with gastric cancer and digestive disorders, as well as doctors treating them.

Plain English
This study looked at gastritis, which is the inflammation of the stomach lining, in pairs of identical (monozygotic) and fraternal (dizygotic) twins to understand how genetics and environment affect its development. Researchers found that both types of twins showed similar levels of agreement in the severity of their gastritis, with 78.6% of the identical twins having concordant (matching) cases of antral atrophy and 92.9% having concordant corpus atrophy. This is significant because it helps clarify that both genetics and environmental factors play a role in gastritis, but the severity stages were generally similar regardless of whether the twins were identical or fraternal. Who this helps: This research benefits doctors and patients by providing insights into the factors influencing gastritis development.

Plain English
This study looked at how a type of MRI called diffusion-weighted imaging (DWI) can help doctors identify inflammation in the intestines of patients with Crohn's disease. They found that a DWI score of 2 or higher was very effective at detecting active disease with 96.9% sensitivity, and a specific measurement (ADC value) could reliably separate healthy bowel sections from inflamed ones with 98% specificity. This matters because it offers a new way to assess disease severity, which can improve treatment decisions for Crohn's disease patients. Who this helps: Patients with Crohn's disease and their doctors.

Plain English
This study looked at whether movements in the liver could help identify the severity of portal hypertension (PH), a serious condition in patients with liver cirrhosis. The researchers analyzed 36 patients and found that certain measurements of liver strain and motion correlated strongly with a direct measurement of portal hypertension. For example, one measurement showed 100% sensitivity for detecting significant forms of PH, which means it was very effective in identifying those who have the condition. Who this helps: This research benefits patients with liver cirrhosis by offering a non-invasive way to diagnose portal hypertension.

Plain English
This study followed nearly 500 patients with Crohn's disease across Europe for five years to understand how their condition progressed after diagnosis. They found that 22% of patients needed surgery, and 36% were hospitalized due to their disease, with significant differences in treatment approaches between Western and Eastern Europe. Importantly, using immunomodulators significantly lowered the chances of surgery and hospital stays. Who this helps: Patients with Crohn's disease can benefit from understanding the effectiveness of different treatments.

Plain English
This study looked at how ulcerative colitis (UC) behaves over the first five years after diagnosis in a group of 717 patients from different parts of Europe. Researchers found that 6% of patients needed surgery to remove part of their colon, and 23% were hospitalized during this time. Notably, treatment with immunomodulators helped lower the chances of hospitalization by half. Who this helps: Patients with ulcerative colitis benefit from this research, as it highlights effective treatment strategies to manage their condition.

Plain English
This study looked at patients who were initially diagnosed with inflammatory bowel disease unclassified (IBDU) to see how their condition progressed over five years. Out of 112 patients with IBDU, 25% were later diagnosed with either Crohn's disease or ulcerative colitis, while 7% continued without a clear diagnosis. Most of these patients had mild disease and received standard treatments, indicating that IBDU typically leads to less severe outcomes compared to other types of inflammatory bowel disease. Who this helps: This research helps doctors and patients better understand the outlook for those diagnosed with IBDU.

Plain English
This study examined a new imaging method using ultrasound to detect changes in liver tissue caused by disease, specifically focusing on fibrotic tissue. Researchers compared 23 healthy individuals to 21 with hepatitis and 16 with liver cirrhosis. They found that the average tissue strain was significantly different between groups: healthy individuals had a strain of 13.30, hepatitis patients 7.12, and cirrhosis patients only 3.95 micrometers per centimeter, indicating that this imaging method can effectively distinguish between stages of liver disease. Who this helps: This benefits patients with liver conditions by providing better diagnostic tools for their doctors.

Plain English
This study examined the genetic factors that increase the risk of diverticular disease, a condition where pouches form in the colon, leading to complications like pain and bleeding. Researchers analyzed data from nearly 32,000 patients and over 419,000 control subjects, and they found 48 genetic locations linked to the disease, with 12 of these being new discoveries. One specific genetic variant was found to increase the risk of diverticulitis (a complication of the disease) by 32% and others also showed increased risk. Who this helps: This research helps patients with diverticular disease by identifying genetic risks, which can lead to better prevention and treatment strategies.

Plain English
This study looked at a new method for detecting colon cancer and pre-cancerous growths using a special dye called methylene blue that is taken by mouth. Researchers found that patients who took the higher dose (200 mg) of the dye had a significant increase in detection of important lesions—over 56% compared to nearly 48% in those who took a placebo. This matters because better detection can lead to earlier treatment and improved outcomes for patients. Who this helps: Patients undergoing colon cancer screening.

Plain English
This study looked at how high levels of bile acids during intrahepatic cholestasis of pregnancy (a liver condition in pregnant women) relate to the risks of stillbirth and preterm birth. Researchers analyzed data from over 5,500 cases and found that the risk of stillbirth increases significantly when bile acid levels reach 100 µmol/L or higher, with a rate of 3.44% compared to just 0.13% in those with lower levels. The findings matter because they help reassure most women with this condition, as their bile acid levels are often below this threshold, indicating their risk of stillbirth is similar to that of the general pregnant population. Who this helps: This helps pregnant women diagnosed with intrahepatic cholestasis and their healthcare providers.

Plain English
This study looked at two proteins in the blood, Nogo-A and placental growth factor (PlGF), to see how they relate to portal hypertension in people with liver cirrhosis. Researchers found that higher levels of PlGF and lower levels of Nogo-A were linked to worsening portal hypertension, with PlGF being particularly useful for diagnosis (it was 76.7% accurate in spotting significant portal hypertension at a specific level). Understanding these proteins can help doctors better assess the severity of liver disease and manage treatments for patients. Who this helps: This helps patients with liver cirrhosis and healthcare providers managing their care.

Plain English
This study looked at how quickly different gastrointestinal cancer cells move and how they respond to a substance called 5-aminolevulinic acid (5-ALA), which makes them glow under certain conditions. They found that MKN28 cells from lymph nodes moved more than other cancer cells, showing the highest activity level, while tightly packed cells were mostly still. The research indicates that MKN28 cells also had stronger fluorescence when treated with 5-ALA. Who this helps: This helps doctors and researchers understanding cancer cell behavior, which can improve treatment strategies.

Plain English
This study focused on assessing how well the Lemann Index (LI) measures the overall impact of Crohn's disease on patients, compared to traditional measures like quality of life and disease activity. Researchers found a strong link between the LI and quality of life scores (with a correlation coefficient of -0.812), indicating that as the LI increases, quality of life decreases. This is important because it shows the LI could be a useful tool for understanding the broader effects of Crohn’s disease beyond just inflammation. Who this helps: This helps patients with Crohn's disease and their doctors in managing their symptoms and understanding their disease better.

Plain English
This study looked at how resistant the bacteria Helicobacter pylori is to various antibiotics in adults and children in Lithuania between 2013 and 2015. They found that 28% of adults and 22% of children had H. pylori, with resistance to metronidazole being a concern, affecting 32.8% of adults and 25% of children. The rising rates of resistance, especially in children, highlight the need for more research to ensure effective treatments can be developed. Who this helps: Patients, especially children with Helicobacter pylori infections.

Plain English
This study looked at how certain genetic variations might influence the risk of developing diverticulosis, a common digestive disorder, in white men. Researchers found that a specific variant (rs3134646) in the COL3A1 gene was linked to a higher risk, with men carrying this variant being 1.82 times more likely to develop diverticulosis compared to those who do not have it. Understanding these genetic factors is important because it can help identify individuals at risk and potentially guide preventive measures. Who this helps: This helps patients, particularly white men at risk of diverticulosis.

Plain English
This study looked at vitamin D levels in patients newly diagnosed with inflammatory bowel disease (IBD) across Europe. It found that 79% of the 238 patients had low vitamin D levels when diagnosed, and those who needed corticosteroids had even lower levels (average 36 nmol/l). Higher vitamin D levels were linked to better disease activity and quality of life scores, while smokers had the lowest levels of vitamin D. Who this helps: This research benefits patients with IBD and their doctors by highlighting the importance of monitoring and potentially improving vitamin D levels.

Plain English
This study looked at genetic factors that might increase the risk of gastric cancer by examining two specific regions of chromosomes in nearly 2,000 patients and over 2,000 controls from European backgrounds. The researchers found that certain genetic variants (specifically rs6872282 and rs2585176) are strongly linked to gastric cancer and affect the expression of key genes related to the disease: PTGER4 and PSCA are expressed more in those with the risk variants, while MBOAT7 is expressed less. These findings enhance our understanding of how genetics influences gastric cancer risk in both Asian and European populations. Who this helps: This research benefits patients by providing insights that could lead to better risk assessment and treatment strategies.

Plain English
This study looked at the role of a bacteria called Helicobacter pylori (H. pylori) in causing common stomach issues like peptic ulcers, dyspepsia (indigestion), and gastroesophageal reflux disease (GERD). The findings showed that H. pylori is a major cause of peptic ulcers, but nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin are also important factors. Eradicating H. pylori can improve symptoms of dyspepsia, especially where the bacteria is common. Who this helps: This helps patients with peptic ulcers and dyspepsia.

Plain English
This study examined specific long non-coding RNAs called lincRNAs in gastrointestinal stromal tumors (GISTs), which are rare tumors of the digestive system. Researchers looked at tissue samples from 15 patients and found three lincRNAs that were altered: MALAT1, H19, and FENDRR. Out of these, H19 and FENDRR were confirmed to be significantly increased in a larger group of 22 patients, which might help in understanding how these lincRNAs are related to the development of GISTs. Who this helps: This research benefits patients with GISTs and their doctors by providing insights into potential biomarkers for the disease.

Plain English
This study looked at the connection between specific gene variations (TLR1 and PRKAA1) and the likelihood of developing atrophic gastritis or gastric cancer among people in Europe. Researchers analyzed data from over 1,100 participants and found that a certain variant of the TLR1 gene was associated with an increased risk of gastric cancer, with 29.7% of cancer patients carrying this variant compared to 22.3% of healthy controls. Importantly, neither of these gene variations seemed to increase vulnerability to H. pylori infections, which are known to contribute to stomach issues. Who this helps: This research benefits patients at risk for gastric cancer by identifying genetic factors that may contribute to the disease.

Plain English
This study looked at how common anaemia is in people diagnosed with inflammatory bowel disease (IBD) during their first year. It found that 42% of patients experienced anaemia, with 49% of those with Crohn's disease and 39% with ulcerative colitis developing it at least once in that year. The research highlights that many patients, especially those with more severe or extensive disease, are at higher risk for anaemia, and often do not receive thorough testing for it soon after their diagnosis. Who this helps: This helps patients with IBD and their doctors by identifying the need for better screening and management of anaemia in these patients.

Plain English
The study explored the relationship between variations in specific genes (known as polymorphisms) and the risk of developing gastric cancer in a group of European patients. Researchers compared 474 patients with gastric cancer to 508 individuals without cancer and found that a specific gene variation (rs1051690) was linked to a higher risk of gastric cancer. Specifically, patients with the CT genotype had a 45% increased risk of developing gastric cancer compared to those with the CC genotype. Who this helps: This helps patients at risk for gastric cancer by identifying genetic factors that could inform early detection and prevention strategies.

Plain English
This study looked at the levels of a marker called LINE-1 methylation in 267 tissue samples related to gastric cancer and found that LINE-1 levels were lower in cancer tissues compared to nearby normal tissues. However, this decrease in LINE-1 methylation was not common in the early stages before cancer developed, and it did not show any significant impact on patient survival rates. This matters because understanding these patterns can help researchers determine which markers are useful for predicting cancer progression. Who this helps: This helps researchers and doctors working in cancer diagnosis and treatment.

Plain English
This study looked at the presence of specific autoantibodies in patients with gastric cancer and those with precancerous conditions. Researchers found that 13% of patients with severe precancerous changes had these antibodies, similar to the 12% found in early-stage gastric cancer patients. This is important because it suggests that these antibodies can be detected even before cancer develops, which could help identify high-risk individuals earlier. Who this helps: This helps doctors identify patients who are at higher risk for developing gastric cancer.

Plain English
This study examined different types of blood cells in humans, focusing on microRNAs, which are small molecules that help regulate gene expression. Researchers analyzed blood samples from various cell types and created a detailed database featuring the expression levels of these microRNAs. They found specific patterns and variations in microRNAs linked to each type of blood cell, providing important baseline information for future research. Who this helps: This benefits researchers and doctors by providing a valuable resource for understanding blood-related diseases and developing targeted therapies.

Plain English
This study looked at new ways to assess portal hypertension (high blood pressure in the liver) without needing invasive procedures that can be uncomfortable and costly for patients. Researchers tested 21 different data analysis techniques and found one that does a better job of predicting significant portal hypertension than existing methods, using only noninvasive data. This is important because it offers a safer and more accessible option for doctors to evaluate patients at risk without the drawbacks of traditional methods. Who this helps: Patients with chronic liver disease seeking safer evaluation options.